Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kerri Martinez"'
Publikováno v:
Thrombosis Research. 193:40-44
Extended direct oral anticoagulant (DOAC) therapy may be required for patients with a venous thromboembolism (VTE); thus, DOAC adherence may impact the risk of recurrent VTE or bleeding.This was a retrospective cohort study. Adult patients with a VTE
Autor:
Kerri Martinez, Thomas Delate, Jordan B. King, Kelsey L. Hawkins, Kathleen H. McCool, Nathan P. Clark
Publikováno v:
Journal of managed carespecialty pharmacy. 24(11)
There is increasing demand on pharmacist time within clinical pharmacy services, and pharmacy technicians are a crucial resource for expanding pharmacy practice.To assess the safety and effectiveness of pharmacy technician management of stable, in-ra
Autor:
Sarah J. Billups, Kerri Martinez, Daniel M. Witt, Thomas Delate, Emily Kosirog, Nathan P. Clark
Publikováno v:
Annals of Pharmacotherapy. 49:869-875
Background: Adherence to American College of Chest Physicians (CHEST) guidelines for treatment of acute venous thromboembolism (VTE) has not been formally assessed in the United States, specifically in the subset of patients with renal impairment. Ob
Autor:
Xiangyang Ye, Elaine M. Hylek, Francesco Dentali, Thomas Delate, Nathan P. Clark, Mark Crowther, Walter Ageno, Allison E. Schroeder, David A. Garcia, Kerri Martinez, Daniel M. Witt
Background Whether and when to resume oral anticoagulant therapy for patients who survive warfarin-related intracranial hemorrhage (ICH) remains a dilemma lacking consensus recommendations and high-quality evidence to guide clinical decision making.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84836ded8f075c7066f01536a11445e
http://hdl.handle.net/11383/2052076
http://hdl.handle.net/11383/2052076
Autor:
Elaine M. Hylek, Mark Crowther, Francesco Dentali, Nathan P. Clark, David A. Garcia, Daniel M. Witt, Walter Ageno, Kerri Martinez, Thomas Delate
article i nfo Introduction: Avoiding intracranial hemorrhage (ICH) during warfarin therapy is critical but little is known about factors that affect warfarin-related ICH outcomes. We aimed to define the impact of warfarin on ICH incidence rates and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94cfe9d3a654b7c0bff3b45fa2bfaa00
http://hdl.handle.net/11383/2012752
http://hdl.handle.net/11383/2012752
Publikováno v:
Thrombosis research. 130(2)
When interacting medications, such as doxycycline, are initiated during warfarin therapy, one method to correct for non-therapeutic international normalized ratio (INR) is adjusting the warfarin dose, if necessary. Another approach is preemptive warf
Publikováno v:
Journal of thrombosis and thrombolysis. 31(4)
Typically, the international normalized ratio (INR) is monitored and warfarin dose adjusted, if necessary, to correct non-therapeutic INR after interacting medications, like prednisone, are initiated during warfarin therapy. Preemptively adjusting th
Publikováno v:
Journal of thrombosis and thrombolysis. 27(3)
To describe and compare warfarin therapy use and outcomes between warfarin-receiving patients in hospice or palliative care (HPC) and not in HPC.This retrospective, matched analysis examined warfarin-receiving patients who did (study cohort) and did